Peter Altman - Sep 19, 2025 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Stock symbol
BCDA
Transactions as of
Sep 19, 2025
Transactions value $
$60,000
Form type
4
Date filed
9/23/2025, 09:00 AM
Previous filing
Aug 25, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Altman Peter President and CEO, Director C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE /s/ David McClung, by power of attorney 2025-09-23 0001647542

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Purchase $60K +48K +28.44% $1.25 217K Sep 19, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCDA Warrant (right to buy) Purchase +48K +50.2% 144K Sep 19, 2025 Common Stock 48K $1.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased from the Issuer in a public offering that closed on September 19, 2025, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased.